Remdesivir
Remdesivir is an antiviral drug that has provisional approval in several countries for treating people with severe coronavirus infections. It has been shown to shorten recovery time in people with covid-19 but not to reduce mortality.
Advertisement
Remdesivir is an antiviral drug that has provisional approval in several countries for treating people with severe coronavirus infections. It has been shown to shorten recovery time in people with covid-19 but not to reduce mortality.
A drug trial has found two experimental drugs for Ebola to be so effective that scientists have stopped the trial early so that more people can receive these drugs